Oximes of oxymorphone, naltrexone and naloxone as potent, selective opioid receptor agonists and antagonists
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 26, 1988
Grant Date -
N/A
app pub date -
Sep 23, 1985
filing date -
Sep 23, 1985
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A potent, selective opioid receptor agonist or antagonist exhibiting properties useful for a long-acting analgesic or opiate abuse treatment agent or appetite suppressant having the general formula: ##STR1## wherein R is methyl, cyclopropylmethyl or allyl, and R.sub.1 is an unsubstituted or substituted aryl, aralkyl, heteroaryl, heteroaralkyl or a cycloalkyl group with or without a heteroatom like S,O,N; and the pharmaceutically acceptable salts thereof.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully